213 related articles for article (PubMed ID: 2169851)
1. The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase.
Musk SR; Steel GG
Br J Cancer; 1990 Sep; 62(3):364-7. PubMed ID: 2169851
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.
Ng CE; Bussey AM; Raaphorst GP
Int J Radiat Biol; 1994 Jul; 66(1):49-57. PubMed ID: 8027612
[TBL] [Abstract][Full Text] [Related]
3. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
Stevnsner T; Bohr VA
Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
[TBL] [Abstract][Full Text] [Related]
4. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
Kim JS; Amorino GP; Pyo H; Cao Q; Choy H
Radiother Oncol; 2002 Jan; 62(1):61-7. PubMed ID: 11830313
[TBL] [Abstract][Full Text] [Related]
5. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
6. The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts.
Popanda O; Thielmann HW
Carcinogenesis; 1992 Dec; 13(12):2321-8. PubMed ID: 1335377
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
8. The effect of two topoisomerase inhibitors on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79 cells.
Skov K; Zhou H; Marples B
Radiat Res; 1994 Apr; 138(1 Suppl):S117-20. PubMed ID: 8146313
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
Holm C; Covey JM; Kerrigan D; Pommier Y
Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
[TBL] [Abstract][Full Text] [Related]
10. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
11. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair.
Saleh EM
Tumour Biol; 2015 Nov; 36(11):8985-92. PubMed ID: 26081617
[TBL] [Abstract][Full Text] [Related]
13. DNA topoisomerase inhibitors.
Capranico G; Giaccone G; Zunino F; Garattini S; D'Incalci M
Cancer Chemother Biol Response Modif; 1994; 15():67-86. PubMed ID: 7779607
[No Abstract] [Full Text] [Related]
14. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
Bowman KJ; Newell DR; Calvert AH; Curtin NJ
Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
[TBL] [Abstract][Full Text] [Related]
15. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells.
Gedik CM; Collins AR
Nucleic Acids Res; 1990 Feb; 18(4):1007-13. PubMed ID: 2156221
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Beck WT; Danks MK
Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
[TBL] [Abstract][Full Text] [Related]
18. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
Furukawa M; Harada T; Tanaka T; Kuwano M
Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Sumner AT
J Cell Sci; 1992 Sep; 103 ( Pt 1)():105-15. PubMed ID: 1331132
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
Tsunoda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
